Growth Metrics

Biogen (BIIB) Non-Current Debt (2022 - 2025)

Historic Non-Current Debt for Biogen (BIIB) over the last 9 years, with Q4 2025 value amounting to $6.3 billion.

  • Biogen's Non-Current Debt rose 3825.65% to $6.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $6.3 billion, marking a year-over-year increase of 3825.65%. This contributed to the annual value of $6.3 billion for FY2025, which is 3825.65% up from last year.
  • Biogen's Non-Current Debt amounted to $6.3 billion in Q4 2025, which was up 3825.65% from $4.5 billion recorded in Q4 2024.
  • Biogen's Non-Current Debt's 5-year high stood at $6.8 billion during Q4 2023, with a 5-year trough of $4.5 billion in Q4 2024.
  • Over the past 4 years, Biogen's median Non-Current Debt value was $6.3 billion (recorded in 2022), while the average stood at $6.0 billion.
  • As far as peak fluctuations go, Biogen's Non-Current Debt tumbled by 3301.32% in 2024, and later skyrocketed by 3825.65% in 2025.
  • Quarter analysis of 4 years shows Biogen's Non-Current Debt stood at $6.3 billion in 2022, then increased by 8.08% to $6.8 billion in 2023, then crashed by 33.01% to $4.5 billion in 2024, then skyrocketed by 38.26% to $6.3 billion in 2025.
  • Its Non-Current Debt was $6.3 billion in Q4 2025, compared to $4.5 billion in Q4 2024 and $6.8 billion in Q4 2023.